Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases; May2023, Vol. 227 Issue 9, p1073-10783, 9711p
Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...
Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases; Feb2023, Vol. 227 Issue 3, p332-338, 7p
Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...
Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. 9/15/2022, Vol. 226 Issue 6, p1122-1124. 3p.
Abstract: To the Editor - We would like to thank Zhigang Ren and colleagues [[1]] for the additional valuable information on the immune response after breakthrough infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron varian...
Differences in New Variant of Concern Replication at Physiological Temperatures In Vitro.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. 1/15/2023, Vol. 227 Issue 2, p202-205. 4p.
Abstract: Using multiple cell types and isolates of Delta and Omicron variants of SARS-CoV-2, we report differences in virus production, replication, and infectivity in vitro. Ancestral and Delta SARS-CoV-2 variant exhibit reduced virus production and replicatio...
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. Feb2023, Vol. 227 Issue 3, p344-352. 9p.
Abstract: Background: Four SARS-CoV-2 variants predominated in the United States since 2021. Understanding disease severity related to different SARS-CoV-2 variants remains limited.Method: Viral genome analysis was performed on SARS-CoV-2 clinical isolates circu...
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. 11/15/2022, Vol. 226 Issue 10, p1688-1698. 11p.
Abstract: Background: As of early 2022, the Omicron variants are the predominant circulating lineages globally. Understanding neutralizing antibody responses against Omicron BA.1 and BA.2 after vaccine breakthrough infections will provide insights into BA.2 infe...
Effects of Inactivated Vaccination on Humoral Immune Responses in Patients Infected With Delta or Omicron Variants.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. 9/15/2022, Vol. 226 Issue 6, p1120-1122. 3p.
Abstract: We compared the dynamic levels of IgG and IgM antibodies in patients infected with the delta variant in the nonvaccinated group, the 1-dose vaccine group, and the 2-dose vaccine group. The results showed that regardless of whether it was IgG antibody o...
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases. 12/1/2022, Vol. 226 Issue 11, p1924-1933. 10p.
Abstract: Background: Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters.Methods: We followed 85 801 participants (aged 31-81 years) in 2 large populati...
Impact of Vaccination, Prior Infection and Therapy on Omicron Infection and Mortality.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases; 4/15/2023, Vol. 227 Issue 8, p970-976, 7p
Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...
Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada.
Publication Type: Academic Journal
Source(s): Journal of Infectious Diseases; 4/15/2023, Vol. 227 Issue 8, p977-980, 4p
Abstract: Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...